Aspira Women’s Health enters $1.05 million subordinated loan agreement with Agile Lending

The company said the proceeds are earmarked to refinance January debt and fund general corporate purposes.

Financing statements to perfect the security interests are generally limited to default. If an event of default occurs, the lenders can accelerate the loan, enforce remedies, and repossess collateral.

Aspira Women’s Health entered a subordinated secured term loan with Agile Lending as lead lender, dated July 1, 2026.

The promissory note has principal of $1.05 million and a scheduled maturity date of Jan. 26, 2027. If paid on time, total interest charges would be $441,000.

The loan is subordinated to all senior indebtedness and is secured by a lien on substantially all personal property, including intellectual property.